Patent and Innovation Trends in GLP-1 and Weight Loss Drugs (20202025): What the IP and Science Signal Next This article was powered by Cypris Q, an AI agent that helps R&D teams instantly synthesize insights from patents, scientific literature, and market intelligence from around the globe
Iodine and brain development
At Ghent University, we routinely perform analysis of dried blood samples to check for the presence of a marker indicating how much alcohol an individual has consumed in the past month
The list includes medications with unique pharmacokinetic properties, such as: Clinically, these drugs are primarily prescribed for the treatment of type 2 diabetes, but they also have additional benefits in obesity management, cardiovascular risk reduction, and, to some extent, fatty liver disease
Waiting two or more years for an unapproved drug class is rarely the best option for someone who is losing weight and has medical reasons to stay on treatment
-1775582746855.png&w=3840&q=75)
